Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The…
In a customised study commissioned by Fairfest Media and conducted by NielsenIQ, 71% of eligible respondents claimed OTM provides the…
45% of leaders expect AI agents in workflows within a year; only 30% of workers say the sameJust 22% of…
While 95% of initiatives fail to achieve scale, a small cohort delivers triple-digit productivity gains through governance and operational redesignCLARK,…
GUANGZHOU, China, May 15, 2026 /PRNewswire/ -- In April of this year, AION V saw a 179% year-over-year increase in global…
100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission May 14, 2026 11:43 ET |…
May 11, 2026 04:00 ET | Source: ENA Respiratory MELBOURNE, Australia, May 11, 2026 (GLOBE NEWSWIRE) -- ENA Respiratory, a…
GALWAY, Ireland, May 10, 2026 (GLOBE NEWSWIRE) -- WhiteSwell, a clinical-stage medtech company pioneering a new treatment paradigm for acute…
May 08, 2026 20:45 ET | Source: Amplia Therapuetics Limited Melbourne, Australia, May 08, 2026 (GLOBE NEWSWIRE) -- HIGHLIGHTS Amplia…
MAASTRICHT, Netherlands, May 6, 2026 /PRNewswire/ -- A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 shows…